LOC150356 Inhibitors
CHADL, or Chondroadherin-Like, is a protein encoded by the CHADL gene in humans. This protein belongs to a family of extracellular matrix (ECM) proteins, which play a critical role in providing structural and biochemical support to the surrounding cells. ECM proteins are essential for the proper organization of the tissue architecture and for the modulation of cellular functions such as adhesion, migration, differentiation, and proliferationChondroadherin-Like, as its name suggests, shares structural similarities with Chondroadherin (CHAD), a protein known to mediate the adhesion of cells to the matrix and influence cellular signaling pathways that are crucial for cartilage integrity and function. CHADL is thought to have a similar role in the interaction between cells and the ECM, potentially contributing to the maintenance of tissue structure and the transmission of mechanical and biochemical signals that regulate cellular behavior.
Although the exact physiological and biochemical functions of CHADL are not completely understood, it is postulated to be involved in cartilage development and homeostasis, similar to other cartilage ECM proteins. Due to its structural properties and localization, CHADL might interact with cell surface receptors such as integrins, which are known to mediate cell-matrix interactions and influence cell signaling pathways related to growth, survival, and repair.Mutations or dysregulation of ECM proteins, including CHADL, can have significant implications for tissue function and are often associated with a variety of disorders, including skeletal dysplasias, osteoarthritis, and other connective tissue diseases. Research into CHADL's specific interactions and functions could provide insights into the pathophysiology of these conditions and potentially lead to the development of targeted therapies aimed at restoring normal tissue function and integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is known to inhibit TGF-β signaling, which could indirectly affect CHADL, especially if it's involved in processes like extracellular matrix organization or cell differentiation. | ||||||
Glycyrrhizic acid | 1405-86-3 | sc-279186 sc-279186A | 1 g 25 g | $57.00 $333.00 | 7 | |
Glycyrrhizin inhibits hyaluronidase activity, potentially impacting extracellular matrix dynamics, which might indirectly influence CHADL's function or expression. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Cilengitide selectively inhibits integrins αvβ3 and αvβ5, potentially affecting cell adhesion and migration processes that could be related to CHADL's biological role. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is a broad-spectrum matrix metalloproteinase inhibitor, which may indirectly modulate CHADL's function or expression by altering extracellular matrix remodeling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinase (ROCK), potentially impacting cell motility and adhesion, processes that could intersect with CHADL's function. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 inhibits Wnt/β-catenin signaling, potentially impacting pathways related to cell adhesion and extracellular matrix interactions, which might influence CHADL. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine inhibits the Hedgehog signaling pathway, which could indirectly affect CHADL, especially if it's involved in developmental processes or cell differentiation. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT is a gamma-secretase inhibitor that blocks Notch signaling, potentially affecting CHADL's function if it is involved in cell-cell communication or differentiation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine inhibits autophagy, a process that might intersect with CHADL's function, especially if it plays a role in cellular stress responses or protein degradation. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib inhibits Janus kinases (JAKs), potentially affecting signaling pathways that might intersect with CHADL's biological role. | ||||||